BRCA2 Antikörper (AA 2737-2874)
-
- Target Alle BRCA2 Antikörper anzeigen
- BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
-
Bindungsspezifität
- AA 2737-2874
-
Reaktivität
- Zebrafisch (Danio rerio)
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BRCA2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Kreuzreaktivität
- Zebrafisch (Danio rerio)
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Zebrafish Breast cancer 2, early onset protein (2737-2874AA)
- Isotyp
- IgG
- Top Product
- Discover our top product BRCA2 Primärantikörper
-
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 21-130) antibody
BRCA2 Reaktivität: Human WB, ELISA, IHC (p), IHC (fro), IF (cc), IF (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) antibodyBRCA2 Reaktivität: Human, Ratte WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 2990-3232) antibodyBRCA2 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 3319-3418) antibodyBRCA2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 3D12 unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 1-300) antibodyBRCA2 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 2913-3151) antibodyBRCA2 Reaktivität: Ratte WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 2308-2537) antibodyBRCA2 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (pSer3291) antibodyBRCA2 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 251-495) antibodyBRCA2 Reaktivität: Human WB Wirt: Maus Monoclonal 1643CT739-91-87 unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (N-Term) antibodyBRCA2 Reaktivität: Human, Ratte, Affe WB, IHC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Recommended dilution: WB:1:500-1:5000,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
- Andere Bezeichnung
- brca2 (BRCA2 Produkte)
- Hintergrund
- Breast cancer 2, early onset, brca2
- UniProt
- F1R8E8
- Pathways
- DNA Reparatur, M Phase, Maintenance of Protein Location
-
